Affinity Groups

There are no Affinity Groups associated with this topic. View All Affinity Groups.

Announcements

There are no announcements with this tag. View All Announcements.

Topics from Ask.CI

Loading topics from Ask.CI...

Engagements

Re-engineering Lilly’s KisunlaTM into a novel antibody targeting IL13RA2 against GBM using AI-driven macromolecular modeling
Atrium Health Levine Cancer
  • Summary and objectives of the proposed experiments: 
  1. An initial research-based Ab (scFv47, discovered by our collaborator Dr. Balyasnikova) model, modeling Ab-Ag (IL13RA2 against GBM) protein complex, and identifying the binding sites (epitopes) using ROSETTA and AlphaFold2 multimer tools.
  2. Graft the CDRs of scFv (single-chain variable fragment) of antibody or Bispecific T cell engagers (BTEs) onto the template Ab, the framework of Lilly's Kisunla™ Ab drug.
  3. Modify, improve, and optimize the overall or full antibody protein structures using AI-driven macromolecule modeling (AlphaFold3).
  4. Explore single nucleotide polymorphism (SNP), pathogenic genetic variants and N-glycosylation of IL13RA2 (target) protein domain interacting with the Ab candidates among the patient population using ROSETTA software packages.
Status: In Progress

People with Expertise

Pramod Misra

Georgia Institute of Technology

Programs

ACCESS CSSN

Roles

cssn

Pramod Misra

Expertise

+13 more tags

Devin Bayly

University of Arizona

Programs

ACCESS CSSN, Campus Champions, CCMNet

Roles

research computing facilitator, Affinity Group Leader, CCMNet

User

Expertise

Fan Chen

Programs

ACCESS CSSN

Roles

mentor, cssn, CIP

Placeholder headshot

Expertise

People with Interest

Devin Bayly

University of Arizona

Programs

ACCESS CSSN, Campus Champions, CCMNet

Roles

research computing facilitator, Affinity Group Leader, CCMNet

User

Interests

Programs

CCMNet

Roles

CCMNet

Interests

ali eydgahi

Programs

CCMNet

Roles

CCMNet

Placeholder headshot

Interests